| Year |
Citation |
Score |
| 2023 |
Sohn MB, Gao B, Kendrick C, Srivastava A, Isakova T, Gassman JJ, Fried LF, Wolf M, Cheung AK, Raphael KL, Vinales PC, Middleton JP, Pabalan A, Raj DS. Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney International Reports. 9: 671-685. PMID 38481512 DOI: 10.1016/j.ekir.2023.12.017 |
0.31 |
|
| 2023 |
Leidner AS, Cai X, Zelnick LR, Lee J, Bansal N, Pasch A, Kansal M, Chen J, Anderson AH, Sondheimer JH, Lash JP, Townsend RR, Go AS, Feldman HI, Shah SJ, ... Wolf M, et al. Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) Study. Kidney Medicine. 5: 100723. PMID 37915961 DOI: 10.1016/j.xkme.2023.100723 |
0.347 |
|
| 2023 |
Wolf M. FGF23 AND ALTERED MINERAL HOMEOSTASIS IN KIDNEY DISEASE AND FOLLOWING INTRAVENOUS IRON. Transactions of the American Clinical and Climatological Association. 133: 262-273. PMID 37701608 |
0.402 |
|
| 2023 |
Edmonston D, Grabner A, Wolf M. FGF23 and klotho at the intersection of kidney and cardiovascular disease. Nature Reviews. Cardiology. PMID 37443358 DOI: 10.1038/s41569-023-00903-0 |
0.422 |
|
| 2023 |
Sunderraj A, Wong M, Gutiérrez OM, Wolf M, Akhabue E, Carnethon MR, Yancy CW, Isakova T. Associations of FGF23 with 10-year change in eGFR and UACR with incident CKD in the CARDIA cohort. Kidney360. PMID 37265357 DOI: 10.34067/KID.0000000000000172 |
0.359 |
|
| 2022 |
Fujii N, Hamano T, Hsu JY, Imai E, Akizawa T, Nitta K, Watanabe T, Iimuro S, Ohashi Y, Matsuo S, Makino H, Hishida A, Alper AB, Horwitz EJ, Hsu CY, ... ... Wolf M, et al. A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan. American Journal of Nephrology. 1-14. PMID 35226897 DOI: 10.1159/000521386 |
0.34 |
|
| 2021 |
Akhabue E, Wong M, Mehta R, Isakova T, Wolf M, Yancy C, Gutierrez OM, Carnethon M. Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study. American Heart Journal. 245: 10-18. PMID 34861237 DOI: 10.1016/j.ahj.2021.11.009 |
0.329 |
|
| 2021 |
Courbon G, Francis C, Gerber C, Neuburg S, Wang X, Lynch E, Isakova T, Babitt JL, Wolf M, Martin A, David V. Lipocalin 2 stimulates bone fibroblast growth factor 23 production in chronic kidney disease. Bone Research. 9: 35. PMID 34334787 DOI: 10.1038/s41413-021-00154-0 |
0.375 |
|
| 2020 |
Kula AJ, Katz R, Zelnick LR, Soliman E, Go A, Shlipak M, Deo R, Ky B, DeBoer I, Anderson A, Christenson R, Seliger SL, Defilippi C, Feldman HI, Wolf M, et al. Association of circulating cardiac biomarkers with electrocardiographic abnormalities in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 33367652 DOI: 10.1093/ndt/gfaa296 |
0.322 |
|
| 2020 |
Saraf SL, Hsu JY, Ricardo AC, Mehta R, Chen J, Chen TK, Fischer MJ, Hamm L, Sondheimer J, Weir MR, Zhang X, Wolf M, Lash JP. Anemia and Incident End-Stage Kidney Disease. Kidney360. 1: 623-630. PMID 33117990 DOI: 10.34067/Kid.0000852020 |
0.429 |
|
| 2020 |
Gitomer B, Pereira R, Salusky IB, Stoneback JW, Isakova T, Cai X, Dalrymple LS, Ofsthun N, You Z, Malluche HH, Maddux F, George D, Torres V, Chapman A, Steinman TI, ... Wolf M, et al. Mineral bone disease in autosomal dominant polycystic kidney disease. Kidney International. PMID 32926884 DOI: 10.1016/J.Kint.2020.07.041 |
0.389 |
|
| 2020 |
Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, ... ... Wolf M, et al. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 32866540 DOI: 10.1053/J.Ajkd.2020.07.011 |
0.414 |
|
| 2020 |
Edmonston DL, Roe MT, Block G, Conway PT, Dember LM, DiBattiste PM, Greene T, Hariri A, Inker LA, Isakova T, Montez-Rath ME, Nkulikiyinka R, Polidori D, Roessig L, Tangri N, ... ... Wolf M, et al. Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 32768631 DOI: 10.1053/J.Ajkd.2020.05.026 |
0.331 |
|
| 2020 |
Frazier R, Hodakowski A, Cai X, Lee J, Zakarija A, Stein B, David V, Wolf M, Isakova T, Mehta R. Effects of ferric carboxymaltose on markers of mineral and bone metabolism: a single-center prospective observational study of women with iron deficiency. Bone. 115559. PMID 32730929 DOI: 10.1016/J.Bone.2020.115559 |
0.343 |
|
| 2020 |
Florenzano P, Jimenez M, Ferreira CR, Nesterova G, Roberts MS, Tella SH, Fernandez de Castro L, Gafni RI, Wolf M, Jüppner H, Gales B, Wesseling-Perry K, Markovich D, Gahl WA, Salusky IB, et al. Nephropathic Cystinosis: A Distinct Form of CKD-Mineral and Bone Disorder that Provides Novel Insights into the Regulation of FGF23. Journal of the American Society of Nephrology : Jasn. PMID 32631973 DOI: 10.1681/Asn.2019111172 |
0.361 |
|
| 2020 |
Ishigami J, Taliercio JT, Feldman HI, Srivastava A, Townsend RR, Cohen DL, Horwitz EJ, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, et al. Fibroblast Growth Factor 23 and Risk of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : Jasn. PMID 32576601 DOI: 10.1681/Asn.2019101106 |
0.478 |
|
| 2020 |
Nelson AJ, Raggi P, Wolf M, Gold AM, Chertow GM, Roe MT. Targeting Vascular Calcification in Chronic Kidney Disease. Jacc. Basic to Translational Science. 5: 398-412. PMID 32368697 DOI: 10.1016/J.Jacbts.2020.02.002 |
0.438 |
|
| 2020 |
Srivastava A, Cai X, Lee J, Li W, Larive B, Kendrick C, Gassman JJ, Middleton JP, Carr J, Raphael KL, Cheung AK, Raj DS, Chonchol MB, Fried LF, Block GA, ... ... Wolf M, et al. Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 32345747 DOI: 10.2215/Cjn.13201019 |
0.324 |
|
| 2020 |
Anand S, Jagannathan R, Gupta R, Mohan S, Prabhakaran D, Wolf M. Fibroblast Growth Factor-23 and a Vegetarian Diet. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. PMID 32247648 DOI: 10.1053/J.Jrn.2020.02.004 |
0.356 |
|
| 2020 |
Wolf M, Block GA, Chertow GM, Cooper K, Fouqueray B, Moe SM, Sun Y, Tomlin H, Vervloet M, Oberbauer R. Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis. Clinical Kidney Journal. 13: 75-84. PMID 32082556 DOI: 10.1093/Ckj/Sfz034 |
0.38 |
|
| 2020 |
Grabner A, Wolf M. Kidney to bone via bedside to bench…and back? The Journal of Clinical Investigation. PMID 32065594 DOI: 10.1172/Jci135213 |
0.407 |
|
| 2020 |
Willey JZ, Moon YP, Husain SA, Elkind MSV, Sacco RL, Wolf M, Cheung K, Wright CB, Mohan S. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study. Plos One. 15: e0226509. PMID 31940363 DOI: 10.1371/Journal.Pone.0226509 |
0.351 |
|
| 2019 |
Bansal N, Katz R, Appel L, Denburg M, Feldman H, Go AS, He J, Hoofnagle A, Isakova T, Kestenbaum B, Kusek J, Lash J, Leonard M, Rahman M, Robinson-Cohen C, ... Wolf M, et al. Vitamin D Metabolic Ratio and Risks of Death and CKD Progression. Kidney International Reports. 4: 1598-1607. PMID 31891001 DOI: 10.1016/J.Ekir.2019.08.014 |
0.389 |
|
| 2019 |
Mehta R, Cai X, Lee J, Xie D, Wang X, Scialla J, Anderson AH, Taliercio J, Dobre M, Chen J, Fischer M, Leonard M, Lash J, Hsu CY, de Boer IH, ... ... Wolf M, et al. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31864822 DOI: 10.1053/J.Ajkd.2019.09.009 |
0.498 |
|
| 2019 |
Raphael KL, Isakova T, Ix JH, Raj DS, Wolf M, Fried LF, Gassman JJ, Kendrick C, Larive B, Flessner MF, Mendley SR, Hostetter TH, Block GA, Li P, Middleton JP, et al. A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. Journal of the American Society of Nephrology : Jasn. PMID 31848294 DOI: 10.1681/Asn.2019030287 |
0.305 |
|
| 2019 |
Musgrove J, Wolf M. Regulation and Effects of FGF23 in Chronic Kidney Disease. Annual Review of Physiology. PMID 31743079 DOI: 10.1146/Annurev-Physiol-021119-034650 |
0.488 |
|
| 2019 |
Edmonston DL, Parikh KS, Rajagopal S, Shaw LK, Abraham D, Grabner A, Sparks MA, Wolf M. Pulmonary Hypertension Subtypes and Mortality in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31732231 DOI: 10.1053/J.Ajkd.2019.08.027 |
0.39 |
|
| 2019 |
Ishigami J, Taliercio J, Feldman H, Srivastava A, Townsend R, Cohen D, Horwitz E, Rao P, Charleston J, Fink JC, Ricardo AC, Sondheimer J, Chen TK, Wolf M, Isakova T, et al. Inflammatory Markers and Incidence of Hospitalization with Infection in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Epidemiology. PMID 31673705 DOI: 10.1093/Aje/Kwz246 |
0.308 |
|
| 2019 |
Francis C, Courbon G, Gerber C, Neuburg S, Wang X, Dussold C, Capella M, Qi L, Isakova T, Mehta R, Martin A, Wolf M, David V. Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease. Kidney International. PMID 31668632 DOI: 10.1016/J.Kint.2019.07.026 |
0.462 |
|
| 2019 |
Isakova T, Cai X, Lee J, Mehta R, Zhang X, Yang W, Nessel L, Anderson AH, Lo J, Porter A, Nunes JW, Negrea L, Hamm L, Horwitz E, Chen J, ... ... Wolf M, et al. Longitudinal Evolution of Markers of Mineral Metabolism in Patients With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31668375 DOI: 10.1053/J.Ajkd.2019.07.022 |
0.404 |
|
| 2019 |
Emrich IE, Dederer J, Kircher A, Klemis V, Lennartz CS, Untersteller K, Wagenpfeil S, Fliser D, Wolf M, Heine GH. Does a rise in plasma erythropoietin after high-altitude exposure affect FGF23 in healthy volunteers on a normal or low-phosphorus diet? Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. PMID 31653518 DOI: 10.1016/J.Numecd.2019.09.002 |
0.343 |
|
| 2019 |
Taylor A, Yanucil C, Musgrove J, Shi M, Ide S, Souma T, Faul C, Wolf M, Grabner A. FGFR4 does not contribute to progression of chronic kidney disease. Scientific Reports. 9: 14023. PMID 31575945 DOI: 10.1038/S41598-019-50669-0 |
0.513 |
|
| 2019 |
Edmonston D, Wolf M. FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. Nature Reviews. Nephrology. PMID 31519999 DOI: 10.1038/S41581-019-0189-5 |
0.399 |
|
| 2019 |
Edmonston D, Wojdyla D, Mehta R, Cai X, Lora C, Cohen D, Townsend RR, He J, Go AS, Kusek J, Weir MR, Isakova T, Pencina M, Wolf M. Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 31445926 DOI: 10.1053/J.Ajkd.2019.05.026 |
0.426 |
|
| 2019 |
Block GA, Block MS, Smits G, Mehta R, Isakova T, Wolf M, Chertow GM. A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD. Journal of the American Society of Nephrology : Jasn. PMID 31278194 DOI: 10.1681/Asn.2018101016 |
0.408 |
|
| 2019 |
Canney M, Djurdjev O, Tang M, Zierold C, Blocki F, Wolf M, Levin A. GFR-Specific versus GFR-Agnostic Cutoffs for Parathyroid Hormone and Fibroblast Growth Factor-23 in Advanced Chronic Kidney Disease. American Journal of Nephrology. 1-10. PMID 31238301 DOI: 10.1159/000501189 |
0.499 |
|
| 2019 |
Yokoyama K, Fukagawa M, Akiba T, Nakayama M, Ito K, Hanaki K, Wolf M, Hirakata H. Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study. Scientific Reports. 9: 8877. PMID 31222044 DOI: 10.1038/S41598-019-45335-4 |
0.335 |
|
| 2019 |
Paluch AE, Pool LR, Isakova T, Lewis CE, Mehta R, Schreiner PJ, Sidney S, Wolf M, Carnethon MR. Association of Fitness With Racial Differences in Chronic Kidney Disease. American Journal of Preventive Medicine. PMID 31122794 DOI: 10.1016/J.Amepre.2019.02.016 |
0.423 |
|
| 2019 |
Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M. Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. Journal of the American Society of Nephrology : Jasn. PMID 31085679 DOI: 10.1681/Asn.2018101058 |
0.468 |
|
| 2019 |
Dussold C, Gerber C, White S, Wang X, Qi L, Francis C, Capella M, Courbon G, Wang J, Li C, Feng JQ, Isakova T, Wolf M, David V, Martin A. DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. Bone Research. 7: 12. PMID 31044094 DOI: 10.1038/S41413-019-0051-1 |
0.448 |
|
| 2019 |
Bundy JD, Cai X, Scialla JJ, Dobre MA, Chen J, Hsu CY, Leonard MB, Go AS, Rao PS, Lash JP, Townsend RR, Feldman HI, de Boer IH, Block GA, Wolf M, et al. Serum Calcification Propensity and Coronary Artery Calcification Among Patients With CKD: The CRIC (Chronic Renal Insufficiency Cohort) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30935773 DOI: 10.1053/J.Ajkd.2019.01.024 |
0.44 |
|
| 2019 |
Brown L, Luciano A, Pendergast J, Khairallah P, Anderson CAM, Sondheimer J, Hamm LL, Ricardo AC, Rao P, Rahman M, Miller ER, Sha D, Xie D, Feldman HI, Asplin J, ... Wolf M, et al. Predictors of Net Acid Excretion in the Chronic Renal Insufficiency Cohort (CRIC) Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30910373 DOI: 10.1053/J.Ajkd.2018.12.043 |
0.413 |
|
| 2019 |
Jovanovich A, You Z, Isakova T, Nowak K, Cheung A, Wolf M, Chonchol M, Kendrick J. Fibroblast Growth Factor 23 Trajectories in Chronic Hemodialysis Patients: Lessons from the HEMO Study. American Journal of Nephrology. 49: 263-270. PMID 30820005 DOI: 10.1159/000497445 |
0.377 |
|
| 2019 |
Lunyera J, Davenport CA, Pendergast J, Musani SK, Bhavsar NA, Sims M, Mwasongwe S, Wolf M, Diamantidis CJ, Boulware LE, Scialla JJ. Modifiers of Plasma 25-hydroxyvitamin D and Chronic Kidney Disease Outcomes in Black Americans: The Jackson Heart Study. The Journal of Clinical Endocrinology and Metabolism. PMID 30668751 DOI: 10.1210/Jc.2018-01747 |
0.335 |
|
| 2019 |
Iqbal T, Wolf M, Muckadell PSd, Zoller H. PTH-137 Phosphare studies: important changes in phosphate homeostasis and bone metabolism after IV iron Gut. 68. DOI: 10.1136/Gutjnl-2019-Bsgabstracts.196 |
0.357 |
|
| 2018 |
Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, Go AS, He J, Xie D, Thompson S, Budoff M, et al. Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30545708 DOI: 10.1053/J.Ajkd.2018.09.012 |
0.412 |
|
| 2018 |
Husain SA, Willey JZ, Park Moon Y, Elkind MSV, Sacco RL, Wolf M, Cheung K, Wright CB, Mohan S. Creatinine- versus cystatin C-based renal function assessment in the Northern Manhattan Study. Plos One. 13: e0206839. PMID 30427947 DOI: 10.1371/Journal.Pone.0206839 |
0.359 |
|
| 2018 |
Akhabue E, Vu TT, Vaidya A, Michos ED, de Boer IH, Kestenbaum B, Allison M, Szklo M, Ouyang P, Yancy CW, Wolf M, Isakova T, Carnethon MR. Fibroblast Growth Factor-23, Heart Failure Risk, and Renin-Angiotensin-Aldosterone-System Blockade in Hypertension: The Multi-Ethnic Study of Atherosclerosis. American Journal of Hypertension. PMID 30256890 DOI: 10.1093/Ajh/Hpy142 |
0.373 |
|
| 2018 |
Robinson-Cohen C, Bartz TM, Lai D, Ikizler TA, Peacock M, Imel EA, Michos ED, Foroud TM, Akesson K, Taylor KD, Malmgren L, Matsushita K, Nethander M, Eriksson J, Ohlsson C, ... ... Wolf M, et al. Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. Journal of the American Society of Nephrology : Jasn. PMID 30217807 DOI: 10.1681/Asn.2018020192 |
0.398 |
|
| 2018 |
Marebwa BK, Adams RJ, Magwood GS, Kindy M, Wilmskoetter J, Wolf M, Bonilha L. Fibroblast growth factor23 is associated with axonal integrity and neural network architecture in the human frontal lobes. Plos One. 13: e0203460. PMID 30192823 DOI: 10.1371/Journal.Pone.0203460 |
0.409 |
|
| 2018 |
Mehta R, Cai X, Hodakowski A, Thyagarajan B, Zeng D, Zee PC, Wohlgemuth WK, Redline S, Lash JP, Wolf M, Isakova T. Sleep disordered breathing and fibroblast growth factor 23 in the Hispanic Community Health Study/Study of Latinos. Bone. 114: 278-284. PMID 29986841 DOI: 10.1016/J.Bone.2018.06.024 |
0.336 |
|
| 2018 |
Scialla JJ, Brown L, Gurley S, Corcoran DL, Bain JR, Muehlbauer MJ, O'Neal SK, M O'Connell T, Wolf M, Melamed ML, Hostetter TH, Abramowitz MK. Metabolic Changes with Base-Loading in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29934431 DOI: 10.2215/Cjn.01830218 |
0.383 |
|
| 2018 |
Akhabue E, Montag S, Reis JP, Pool LR, Mehta R, Yancy CW, Zhao L, Wolf M, Gutierrez OM, Carnethon MR, Isakova T. FGF23 (Fibroblast Growth Factor-23) and Incident Hypertension in Young and Middle-Aged Adults: The CARDIA Study (Coronary Artery Risk Development in Young Adults). Hypertension (Dallas, Tex. : 1979). PMID 29712737 DOI: 10.1161/Hypertensionaha.118.11060 |
0.364 |
|
| 2018 |
Block GA, Rosenbaum DP, Yan A, Greasley PJ, Chertow GM, Wolf M. The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29617976 DOI: 10.1093/Ndt/Gfy061 |
0.419 |
|
| 2018 |
Leaf DE, Siew ED, Eisenga MF, Singh K, Mc Causland FR, Srivastava A, Ikizler TA, Ware LB, Ginde AA, Kellum JA, Palevsky PM, Wolf M, Waikar SS. Fibroblast Growth Factor 23 Associates with Death in Critically Ill Patients. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29519954 DOI: 10.2215/Cjn.10810917 |
0.388 |
|
| 2018 |
Vervloet M, Cooper K, Block G, Chertow G, Fouqueray B, Moe S, Sun Y, Tomlin H, Wolf M, Oberbauer R. Fp378Baseline Levels Of Fgf23 And Effects Of Etelcalcetide Nephrology Dialysis Transplantation. 33. DOI: 10.1093/Ndt/Gfy104.Fp378 |
0.336 |
|
| 2018 |
Canney M, Djurdjev O, Tang M, Zierold C, Blocki F, Bonelli F, Wolf M, Levin A. FP377NOVEL RISK-BASED THRESHOLDS FOR BONE MINERAL BIOMARKERS IN ADVANCED CKD Nephrology Dialysis Transplantation. 33: i159-i159. DOI: 10.1093/Ndt/Gfy104.Fp377 |
0.313 |
|
| 2017 |
Neuburg S, Dussold C, Gerber C, Wang X, Francis C, Qi L, David V, Wolf M, Martin A. Genetic background influences cardiac phenotype in murine chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 29309658 DOI: 10.1093/Ndt/Gfx332 |
0.487 |
|
| 2017 |
Isakova T, Cai X, Lee J, Xie D, Wang X, Mehta R, Allen NB, Scialla JJ, Pencina MJ, Anderson AH, Talierco J, Chen J, Fischer MJ, Steigerwalt SP, Leonard MB, ... ... Wolf M, et al. Longitudinal FGF23 Trajectories and Mortality in Patients with CKD. Journal of the American Society of Nephrology : Jasn. PMID 29167351 DOI: 10.1681/Asn.2017070772 |
0.422 |
|
| 2017 |
Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA. FGF23 and Left Ventricular Hypertrophy in Children with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 29025789 DOI: 10.2215/CJN.02110217 |
0.307 |
|
| 2017 |
Mehta R, Cai X, Hodakowski A, Lee J, Leonard M, Ricardo A, Chen J, Hamm L, Sondheimer J, Dobre M, David V, Yang W, Go A, Kusek JW, Feldman H, ... Wolf M, et al. Fibroblast Growth Factor 23 and Anemia in the Chronic Renal Insufficiency Cohort Study. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28784656 DOI: 10.2215/Cjn.03950417 |
0.481 |
|
| 2017 |
Pool LR, Wolf M. FGF23 and Nutritional Metabolism. Annual Review of Nutrition. PMID 28715994 DOI: 10.1146/Annurev-Nutr-071816-064620 |
0.416 |
|
| 2017 |
Chonchol M, Gitomer B, Isakova T, Cai X, Salusky I, Pereira R, Abebe K, Torres V, Steinman TI, Grantham JJ, Chapman AB, Schrier RW, Wolf M. Fibroblast Growth Factor 23 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28705885 DOI: 10.2215/Cjn.12821216 |
0.337 |
|
| 2017 |
Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M, Sharma K, Leonard M, Miller E, Jaar B, Brecklin C, Yang W, Wang X, Feldman H, Wolf M, et al. Acid Load and Phosphorus Homeostasis in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 28645705 DOI: 10.1053/J.Ajkd.2017.04.022 |
0.398 |
|
| 2017 |
He J, Shlipak M, Anderson A, Roy JA, Feldman HI, Kallem RR, Kanthety R, Kusek JW, Ojo A, Rahman M, Ricardo AC, Soliman EZ, Wolf M, Zhang X, Raj D, et al. Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study. Journal of the American Heart Association. 6. PMID 28515118 DOI: 10.1161/Jaha.116.005336 |
0.405 |
|
| 2017 |
Grabner A, Schramm K, Silswal N, Hendrix M, Yanucil C, Czaya B, Singh S, Wolf M, Hermann S, Stypmann J, Di Marco GS, Brand M, Wacker MJ, Faul C. FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Scientific Reports. 7: 1993. PMID 28512310 DOI: 10.1038/S41598-017-02068-6 |
0.419 |
|
| 2017 |
Ahmad FS, Cai X, Kunkel K, Ricardo AC, Lash JP, Raj DS, He J, Anderson AH, Budoff MJ, Wright Nunes JA, Roy J, Wright JT, Go AS, St John Sutton MG, Kusek JW, ... ... Wolf M, et al. Racial/Ethnic Differences in Left Ventricular Structure and Function in Chronic Kidney Disease: The Chronic Renal Insufficiency Cohort. American Journal of Hypertension. PMID 28444108 DOI: 10.1093/Ajh/Hpx058 |
0.441 |
|
| 2017 |
Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT, ... Wolf M, et al. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease. Jama Cardiology. PMID 28329057 DOI: 10.1001/Jamacardio.2017.0363 |
0.407 |
|
| 2017 |
Hsu JY, Roy JA, Xie D, Yang W, Shou H, Anderson AH, Landis JR, Jepson C, Wolf M, Isakova T, Rahman M, Feldman HI. Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 28242844 DOI: 10.2215/Cjn.10301016 |
0.376 |
|
| 2017 |
Resende AL, Elias RM, Wolf M, Dos Reis LM, Graciolli FG, Santos GD, Dias CB, Jorgetti V, Woronik V, Moysés RM. Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis. Cytokine. 91: 124-127. PMID 28063327 DOI: 10.1016/J.Cyto.2016.12.022 |
0.438 |
|
| 2017 |
Wolf M, Block G, Chertow G, Cooper K, Fouqueray B, Moe S, Sun Y, Tomlin H, Vervloet M, Oberbauer R. SO033IMPACT OF ETELCALCETIDE ON FGF23 LEVELS DURING THE TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON HEMODIALYSIS Nephrology Dialysis Transplantation. 32: iii20-iii20. DOI: 10.1093/Ndt/Gfx105.So033 |
0.332 |
|
| 2016 |
Leaf DE, Jacob KA, Srivastava A, Chen ME, Christov M, Jüppner H, Sabbisetti VS, Martin A, Wolf M, Waikar SS. Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness. Journal of the American Society of Nephrology : Jasn. PMID 28028134 DOI: 10.1681/Asn.2016080836 |
0.412 |
|
| 2016 |
Pichler G, Haller MC, Kainz A, Wolf M, Redon J, Oberbauer R. Prognostic value of bone- and vascular-derived molecular biomarkers in hemodialysis and renal transplant patients: a systematic review and meta-analysis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 28025385 DOI: 10.1093/Ndt/Gfw387 |
0.385 |
|
| 2016 |
Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, Lash JP, Chen J, He J, Navaneethan S, Negrea L, Rosas SE, Kretzler M, Nessel L, Xie D, ... ... Wolf M, et al. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease. Kidney International. PMID 28017325 DOI: 10.1016/J.Kint.2016.10.021 |
0.485 |
|
| 2016 |
Bonato FO, Watanabe R, Lemos MM, Cassiolato JL, Wolf M, Canziani ME. Asymptomatic Ventricular Arrhythmia and Clinical Outcomes in Chronic Kidney Disease: A Pilot Study. Cardiorenal Medicine. 7: 66-73. PMID 27994604 DOI: 10.1159/000449260 |
0.429 |
|
| 2016 |
Kosk D, Kramer H, Luke A, Camacho P, Bovet P, Rhule JP, Forrester T, Wolf M, Sempos C, Melamed ML, Dugas LR, Cooper R, Durazo-Arvizu R. Dietary factors and fibroblast growth factor-23 levels in young adults with African ancestry. Journal of Bone and Mineral Metabolism. PMID 27942978 DOI: 10.1007/S00774-016-0804-5 |
0.397 |
|
| 2016 |
Scialla JJ, Asplin J, Dobre M, Chang AR, Lash J, Hsu CY, Kallem RR, Hamm LL, Feldman HI, Chen J, Appel LJ, Anderson CA, Wolf M. Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes. Kidney International. PMID 27914710 DOI: 10.1016/J.Kint.2016.09.012 |
0.369 |
|
| 2016 |
Souma N, Isakova T, Lipiszko D, Sacco RL, Elkind MS, DeRosa JT, Silverberg SJ, Mendez AJ, Dong C, Wright CB, Wolf M. Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study. The Journal of Clinical Endocrinology and Metabolism. jc20162215. PMID 27501282 DOI: 10.1210/Jc.2016-2215 |
0.42 |
|
| 2016 |
Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S, Czaja MJ, Bartz R, Abraham R, Di Marco GS, Brand M, Wolf M, Faul C. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney International. PMID 27457912 DOI: 10.1016/J.Kint.2016.05.019 |
0.339 |
|
| 2016 |
Mehta R, Cai X, Lee J, Scialla JJ, Bansal N, Sondheimer JH, Chen J, Hamm LL, Ricardo AC, Navaneethan SD, Deo R, Rahman M, Feldman HI, Go AS, Isakova T, ... Wolf M, et al. Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study. Jama Cardiology. PMID 27434583 DOI: 10.1001/Jamacardio.2016.1445 |
0.489 |
|
| 2016 |
Lash JP, Ricardo AC, Roy J, Deo R, Fischer M, Flack J, He J, Keane M, Lora C, Ojo A, Rahman M, Steigerwalt S, Tao K, Wolf M, Wright JT, et al. Race/Ethnicity and Cardiovascular Outcomes in Adults With CKD: Findings From the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic CRIC Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27209443 DOI: 10.1053/J.Ajkd.2016.03.429 |
0.422 |
|
| 2016 |
Bansal N, Xie D, Tao K, Chen J, Deo R, Horwitz E, Hsu CY, Kallem RK, Keane MG, Lora CM, Raj D, Soliman EZ, Strauss L, Wolf M, Go AS, et al. Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27073197 DOI: 10.2215/Cjn.10921015 |
0.364 |
|
| 2016 |
Wright CB, Shah NH, Mendez AJ, DeRosa JT, Yoshita M, Elkind MS, Sacco RL, DeCarli C, Rundek T, Silverberg S, Dong C, Wolf M. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study. Stroke; a Journal of Cerebral Circulation. PMID 26956260 DOI: 10.1161/Strokeaha.115.012379 |
0.38 |
|
| 2016 |
Leaf DE, Christov M, Jüppner H, Siew E, Ikizler TA, Bian A, Chen G, Sabbisetti VS, Bonventre JV, Cai X, Wolf M, Waikar SS. Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery. Kidney International. PMID 26924052 DOI: 10.1016/J.Kint.2015.12.035 |
0.446 |
|
| 2016 |
Gutiérrez OM, Parsa A, Isakova T, Scialla JJ, Chen J, Flack JM, Nessel LC, Gupta J, Bellovich KA, Steigerwalt S, Sondheimer JH, Wright JT, Feldman HI, Kusek JW, Lash JP, ... Wolf M, et al. Genetic African Ancestry and Markers of Mineral Metabolism in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26912553 DOI: 10.2215/Cjn.08020715 |
0.388 |
|
| 2016 |
Ali FN, Josefson J, Mendez AJ, Mestan K, Wolf M. Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates. The Journal of Clinical Endocrinology and Metabolism. jc20153709. PMID 26859104 DOI: 10.1210/Jc.2015-3709 |
0.411 |
|
| 2016 |
David V, Wolf M. Pruning the ricket thicket. The Journal of Clinical Investigation. 1-4. PMID 26784540 DOI: 10.1172/Jci85005 |
0.397 |
|
| 2016 |
Wald R, Goldstein MB, Perl J, Kiaii M, Yuen D, Wald RM, Harel Z, Weinstein JJ, Jakubovic B, Leong-Poi H, Kirpalani A, Leipsic J, Dacouris N, Wolf M, Yan AT. The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. The Canadian Journal of Cardiology. 32: 369-77. PMID 26386732 DOI: 10.1016/J.Cjca.2015.07.004 |
0.399 |
|
| 2015 |
Suarez JJ, Isakova T, Anderson CA, Boulware LE, Wolf M, Scialla JJ. Food Access, Chronic Kidney Disease, and Hypertension in the U.S. American Journal of Preventive Medicine. 49: 912-920. PMID 26590940 DOI: 10.1016/J.Amepre.2015.07.017 |
0.367 |
|
| 2015 |
David V, Martin A, Isakova T, Spaulding C, Qi L, Ramirez V, Zumbrennen-Bullough KB, Sun CC, Lin HY, Babitt JL, Wolf M. Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production. Kidney International. PMID 26535997 DOI: 10.1038/Ki.2015.290 |
0.418 |
|
| 2015 |
Wolf M, Mehta R. Fibroblast Growth Factor-23 Fans the Flames of Heart and Kidney Failure. Jacc. Heart Failure. 3: 840-2. PMID 26450002 DOI: 10.1016/J.Jchf.2015.07.008 |
0.402 |
|
| 2015 |
Grabner A, Amaral AP, Schramm K, Singh S, Sloan A, Yanucil C, Li J, Shehadeh LA, Hare JM, David V, Martin A, Fornoni A, Di Marco GS, Kentrup D, Reuter S, ... ... Wolf M, et al. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metabolism. PMID 26437603 DOI: 10.1016/J.Cmet.2015.09.002 |
0.749 |
|
| 2015 |
Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26430087 DOI: 10.2215/Cjn.05220515 |
0.377 |
|
| 2015 |
Scialla JJ, Wolf M. When there will never be a randomized controlled trial. Kidney International. 88: 220-2. PMID 26230199 DOI: 10.1038/Ki.2015.123 |
0.348 |
|
| 2015 |
Wolf M, Weir MR, Kopyt N, Mannon RB, Von Visger J, Deng H, Yue S, Vincenti F. A Prospective Cohort Study of Mineral Metabolism After Kidney Transplantation. Transplantation. PMID 26177089 DOI: 10.1097/Tp.0000000000000823 |
0.363 |
|
| 2015 |
Shah NH, Dong C, Elkind MS, Sacco RL, Mendez AJ, Hudson BI, Silverberg S, Wolf M, Rundek T, Wright CB. Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study. Arteriosclerosis, Thrombosis, and Vascular Biology. PMID 26112008 DOI: 10.1161/Atvbaha.115.305945 |
0.423 |
|
| 2015 |
Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. Journal of the American Society of Nephrology : Jasn. PMID 25967123 DOI: 10.1681/Asn.2015020117 |
0.49 |
|
| 2015 |
Mehta R, Ying GS, Houston S, Isakova T, Nessel L, Ojo A, Go A, Lash J, Kusek J, Grunwald J, Wolf M. Phosphate, fibroblast growth factor 23 and retinopathy in chronic kidney disease: the Chronic Renal Insufficiency Cohort Study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 25910495 DOI: 10.1093/Ndt/Gfv123 |
0.514 |
|
| 2015 |
Dobre M, Yang W, Pan Q, Appel L, Bellovich K, Chen J, Feldman H, Fischer MJ, Ham LL, Hostetter T, Jaar BG, Kallem RR, Rosas SE, Scialla JJ, Wolf M, et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study. Journal of the American Heart Association. 4. PMID 25896890 DOI: 10.1161/Jaha.114.001599 |
0.46 |
|
| 2015 |
Da J, Xie X, Wolf M, Disthabanchong S, Wang J, Zha Y, Lv J, Zhang L, Wang H. Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 25804679 DOI: 10.1053/J.Ajkd.2015.01.009 |
0.441 |
|
| 2015 |
Block GA, Fishbane S, Rodriguez M, Smits G, Shemesh S, Pergola PE, Wolf M, Chertow GM. A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 65: 728-36. PMID 25468387 DOI: 10.1053/J.Ajkd.2014.10.014 |
0.388 |
|
| 2015 |
Eckberg K, Kramer H, Wolf M, Durazo-Arvizu R, Tayo B, Luke A, Cooper R. Impact of westernization on fibroblast growth factor 23 levels among individuals of African ancestry. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 630-5. PMID 25358495 DOI: 10.1093/Ndt/Gfu342 |
0.413 |
|
| 2015 |
Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M. Fibroblast growth factor 23 and incident CKD in type 2 diabetes. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 29-38. PMID 25343949 DOI: 10.2215/Cjn.06190614 |
0.44 |
|
| 2015 |
Hu MC, Shi M, Cho HJ, Adams-Huet B, Paek J, Hill K, Shelton J, Amaral AP, Faul C, Taniguchi M, Wolf M, Brand M, Takahashi M, Kuro-O M, Hill JA, et al. Klotho and phosphate are modulators of pathologic uremic cardiac remodeling. Journal of the American Society of Nephrology : Jasn. 26: 1290-302. PMID 25326585 DOI: 10.1681/Asn.2014050465 |
0.699 |
|
| 2015 |
Bansal N, Hyre Anderson A, Yang W, Christenson RH, deFilippi CR, Deo R, Dries DL, Go AS, He J, Kusek JW, Lash JP, Raj D, Rosas S, Wolf M, Zhang X, et al. High-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide (NT-proBNP) and risk of incident heart failure in patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC) Study. Journal of the American Society of Nephrology : Jasn. 26: 946-56. PMID 25278510 DOI: 10.1681/Asn.2014010108 |
0.414 |
|
| 2015 |
Wolf M. The biomarker niche for fibroblast growth factor 23 testing in CKD. Journal of the American Society of Nephrology : Jasn. 26: 7-9. PMID 25060055 DOI: 10.1681/Asn.2014060621 |
0.396 |
|
| 2015 |
Grabner A, Amaral A, Singh S, Schramm K, Sloan A, Kentrup D, Reuter S, Pavenstaedt H, Marco GSD, Wolf M, Brand M, Faul C. SaO027CARDIO-PATHOLOGICAL EFFECTS OF FGF23 IN CKD ARE MEDIATED BY FGFR4 Nephrology Dialysis Transplantation. 30. DOI: 10.1093/Ndt/Gfv150.04 |
0.739 |
|
| 2014 |
Di Marco GS, Reuter S, Kentrup D, Grabner A, Amaral AP, Fobker M, Stypmann J, Pavenstädt H, Wolf M, Faul C, Brand M. Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 29: 2028-35. PMID 24875663 DOI: 10.1093/Ndt/Gfu190 |
0.704 |
|
| 2014 |
Wolf M, White KE. Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease. Current Opinion in Nephrology and Hypertension. 23: 411-9. PMID 24867675 DOI: 10.1097/01.Mnh.0000447020.74593.6F |
0.495 |
|
| 2014 |
Bernstein EJ, Isakova T, Sullivan ME, Chibnik LB, Wolf M, Kay J. Nephrogenic systemic fibrosis is associated with hypophosphataemia: a case-control study. Rheumatology (Oxford, England). 53: 1613-7. PMID 24706993 DOI: 10.1093/rheumatology/keu151 |
0.313 |
|
| 2014 |
Wright CB, Dong C, Stark M, Silverberg S, Rundek T, Elkind MS, Sacco RL, Mendez A, Wolf M. Plasma FGF23 and the risk of stroke: the Northern Manhattan Study (NOMAS). Neurology. 82: 1700-6. PMID 24706015 DOI: 10.1212/Wnl.0000000000000410 |
0.333 |
|
| 2014 |
Scialla JJ, Wolf M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nature Reviews. Nephrology. 10: 268-78. PMID 24686452 DOI: 10.1038/Nrneph.2014.49 |
0.488 |
|
| 2014 |
Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T, Ojo A, Zhang X, Nessel L, Hamano T, Grunwald JE, Raj DS, Yang W, He J, Lash JP, Go AS, ... ... Wolf M, et al. Fibroblast growth factor-23 and cardiovascular events in CKD. Journal of the American Society of Nephrology : Jasn. 25: 349-60. PMID 24158986 DOI: 10.1681/Asn.2013050465 |
0.436 |
|
| 2014 |
Ferreira G, Guerra G, Schiavenato E, Agena F, Moyses R, David-Neto E, Wolf M. Bone and Mineral Metabolism and Fibroblast Growth Factor 23 Levels After Kidney Donation.: Abstract# A318 Transplantation. 98: 491. DOI: 10.1097/00007890-201407151-01635 |
0.348 |
|
| 2014 |
Kurnatowska I, Grzelak P, Masajtis-Zagajewska A, Kaczmarska M, Stefańczyk L, Vermeer C, Maresz K, Nowicki M, Patel L, Bernard LM, Elder GJ, Leonardis D, Mallamaci F, Tripepi G, D'Arrigo G, ... ... Wolf M, et al. Ckd Pathophysiology And Clinical Studies Nephrology Dialysis Transplantation. 29. DOI: 10.1093/Ndt/Gfu148 |
0.323 |
|
| 2013 |
Dubin RF, Li Y, He J, Jaar BG, Kallem R, Lash JP, Makos G, Rosas SE, Soliman EZ, Townsend RR, Yang W, Go AS, Keane M, Defilippi C, Mishra R, ... Wolf M, et al. Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). Bmc Nephrology. 14: 229. PMID 24148285 DOI: 10.1186/1471-2369-14-229 |
0.382 |
|
| 2013 |
Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, Wolf M, Jüppner H, Hruska K, Wheeler DC. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 457-73. PMID 23763855 DOI: 10.1053/J.Ajkd.2013.03.042 |
0.451 |
|
| 2013 |
Ky B, Shults J, Keane MG, Sutton MS, Wolf M, Feldman HI, Reese PP, Anderson CA, Townsend RR, Deo R, Lo J, Gadegbeku C, Carlow D, Sulik MJ, Leonard MB, et al. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circulation. Heart Failure. 6: 817-24. PMID 23748358 DOI: 10.1161/Circheartfailure.112.000105 |
0.327 |
|
| 2013 |
Christov M, Waikar SS, Pereira RC, Havasi A, Leaf DE, Goltzman D, Pajevic PD, Wolf M, Jüppner H. Plasma FGF23 levels increase rapidly after acute kidney injury. Kidney International. 84: 776-85. PMID 23657144 DOI: 10.1038/Ki.2013.150 |
0.422 |
|
| 2013 |
Evenepoel P, Wolf M. A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Kidney International. 83: 789-91. PMID 23633052 DOI: 10.1038/Ki.2013.21 |
0.43 |
|
| 2013 |
Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, et al. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 670-8. PMID 23489677 DOI: 10.1053/J.Ajkd.2013.01.017 |
0.471 |
|
| 2013 |
Isakova T, Barchi-Chung A, Enfield G, Smith K, Vargas G, Houston J, Xie H, Wahl P, Schiavenato E, Dosch A, Gutiérrez OM, Diego J, Lenz O, Contreras G, Mendez A, ... ... Wolf M, et al. Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 8: 1009-18. PMID 23471131 DOI: 10.2215/Cjn.09250912 |
0.472 |
|
| 2013 |
Leaf DE, Waikar SS, Wolf M, Cremers S, Bhan I, Stern L. Dysregulated mineral metabolism in patients with acute kidney injury and risk of adverse outcomes. Clinical Endocrinology. 79: 491-8. PMID 23414198 DOI: 10.1111/Cen.12172 |
0.427 |
|
| 2013 |
Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, ... ... Wolf M, et al. Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney International. 83: 1159-68. PMID 23389416 DOI: 10.1038/Ki.2013.3 |
0.735 |
|
| 2013 |
Scialla JJ, Astor BC, Isakova T, Xie H, Appel LJ, Wolf M. Mineral metabolites and CKD progression in African Americans. Journal of the American Society of Nephrology : Jasn. 24: 125-35. PMID 23243213 DOI: 10.1681/Asn.2012070713 |
0.481 |
|
| 2013 |
Isakova T, Xie H, Messinger S, Cortazar F, Scialla JJ, Guerra G, Contreras G, Roth D, Burke GW, Molnar MZ, Mucsi I, Wolf M. Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 13: 100-10. PMID 23025566 DOI: 10.1111/J.1600-6143.2012.04281.X |
0.306 |
|
| 2013 |
Leaf DE, Wolf M. A physiologic-based approach to the evaluation of a patient with hyperphosphatemia. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 330-6. PMID 22938849 DOI: 10.1053/j.ajkd.2012.06.026 |
0.3 |
|
| 2013 |
Smith K, deFilippi C, Isakova T, Gutiérrez OM, Laliberte K, Seliger S, Kelley W, Duh SH, Hise M, Christenson R, Wolf M, Januzzi J. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 67-73. PMID 22883134 DOI: 10.1053/J.Ajkd.2012.06.022 |
0.431 |
|
| 2013 |
Houston J, Smith K, Isakova T, Sowden N, Wolf M, Gutiérrez OM. Associations of dietary phosphorus intake, urinary phosphate excretion, and fibroblast growth factor 23 with vascular stiffness in chronic kidney disease. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 23: 12-20. PMID 22406119 DOI: 10.1053/J.Jrn.2011.12.009 |
0.503 |
|
| 2013 |
Houston J, Isakova T, Wolf M. Phosphate Metabolism and Fibroblast Growth Factor 23 in Chronic Kidney Disease Nutritional Management of Renal Disease. 285-308. DOI: 10.1016/B978-0-12-391934-2.00020-5 |
0.331 |
|
| 2012 |
Jüppner H, Wolf M. αKlotho: FGF23 coreceptor and FGF23-regulating hormone. The Journal of Clinical Investigation. 122: 4336-9. PMID 23187136 DOI: 10.1172/Jci67055 |
0.35 |
|
| 2012 |
Isakova T, Wolf M. Partial answers from partial Klotho deficiency. Journal of the American Society of Nephrology : Jasn. 23: 1599-601. PMID 22975670 DOI: 10.1681/Asn.2012080848 |
0.381 |
|
| 2012 |
Ciancio G, Sageshima J, Chen L, Gaynor JJ, Hanson L, Tueros L, Montenora-Velarde E, Gomez C, Kupin W, Guerra G, Mattiazzi A, Fornoni A, Pugliese A, Roth D, Wolf M, et al. Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 3363-76. PMID 22946986 DOI: 10.1111/J.1600-6143.2012.04235.X |
0.357 |
|
| 2012 |
Mangos S, Amaral AP, Faul C, Jüppner H, Reiser J, Wolf M. Expression of fgf23 and αklotho in developing embryonic tissues and adult kidney of the zebrafish, Danio rerio. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 4314-22. PMID 22885518 DOI: 10.1093/Ndt/Gfs335 |
0.716 |
|
| 2012 |
Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM. Effects of phosphate binders in moderate CKD. Journal of the American Society of Nephrology : Jasn. 23: 1407-15. PMID 22822075 DOI: 10.1681/Asn.2012030223 |
0.388 |
|
| 2012 |
deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, Wolf M, Gaggin H, Januzzi J. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clinical Chemistry. 58: 1342-51. PMID 22791885 DOI: 10.1373/Clinchem.2012.185322 |
0.43 |
|
| 2012 |
Leaf DE, Wolf M, Waikar SS, Chase H, Christov M, Cremers S, Stern L. FGF-23 levels in patients with AKI and risk of adverse outcomes. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1217-23. PMID 22700885 DOI: 10.2215/Cjn.00550112 |
0.443 |
|
| 2012 |
Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney International. 82: 737-47. PMID 22622492 DOI: 10.1038/Ki.2012.176 |
0.531 |
|
| 2012 |
Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M, et al. Fibroblast growth factor 23 and Inflammation in CKD. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 1155-62. PMID 22554719 DOI: 10.2215/Cjn.13281211 |
0.396 |
|
| 2012 |
Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM, Miller ER, Bazzano LA, Cuevas M, Glenn MJ, Lustigova E, Kallem RR, Porter AC, Townsend RR, Weir MR, et al. Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort study. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 22: 379-388.e1. PMID 22480598 DOI: 10.1053/J.Jrn.2012.01.026 |
0.434 |
|
| 2012 |
Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, ... Wolf M, et al. Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care. 35: 994-1001. PMID 22446176 DOI: 10.2337/Dc11-2235 |
0.428 |
|
| 2012 |
Nielsen SE, Reinhard H, Zdunek D, Hess G, Gutiérrez OM, Wolf M, Parving HH, Jacobsen PK, Rossing P. Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. Diabetes Research and Clinical Practice. 97: 71-6. PMID 22402306 DOI: 10.1016/J.Diabres.2012.02.007 |
0.327 |
|
| 2012 |
Wahl P, Wolf M. FGF23 in chronic kidney disease. Advances in Experimental Medicine and Biology. 728: 107-25. PMID 22396166 DOI: 10.1007/978-1-4614-0887-1_8 |
0.514 |
|
| 2012 |
Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M, Collerone G, Keating L, Jüppner H, Wolf M. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 820-8. PMID 22383746 DOI: 10.2215/Cjn.11721111 |
0.413 |
|
| 2012 |
Gutiérrez OM, Smith KT, Barchi-Chung A, Patel NM, Isakova T, Wolf M. (1-34) Parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 139-45. PMID 22246283 DOI: 10.2215/Cjn.06240611 |
0.382 |
|
| 2012 |
Kanbay M, Wolf M, Selcoki Y, Solak Y, Ikizek M, Uysal S, Segall L, Armutcu F, Eryonucu B, Duranay M, Goldsmith D, Covic A. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. International Urology and Nephrology. 44: 1169-75. PMID 22130958 DOI: 10.1007/S11255-011-0076-X |
0.479 |
|
| 2012 |
Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, Wolf M. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 12: 379-87. PMID 22054244 DOI: 10.1111/J.1600-6143.2011.03826.X |
0.324 |
|
| 2012 |
Amaral AP, Oskouei B, Hu M, Moe O, Kuro-o M, Brand M, Hare J, Wolf M, Faul C. Fibroblast Growth Factor 23 Induces Left Ventricular Hypertrophy Journal of the American College of Cardiology. 59. DOI: 10.1016/S0735-1097(12)61060-2 |
0.755 |
|
| 2011 |
Gutiérrez OM, Wolf M, Taylor EN. Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2871-8. PMID 22034506 DOI: 10.2215/Cjn.02740311 |
0.471 |
|
| 2011 |
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, ... ... Wolf M, et al. FGF23 induces left ventricular hypertrophy. The Journal of Clinical Investigation. 121: 4393-408. PMID 21985788 DOI: 10.1172/Jci46122 |
0.771 |
|
| 2011 |
Scialla JJ, Leonard MB, Townsend RR, Appel L, Wolf M, Budoff MJ, Chen J, Lustigova E, Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir MR, et al. Correlates of osteoprotegerin and association with aortic pulse wave velocity in patients with chronic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2612-9. PMID 21940840 DOI: 10.2215/Cjn.03910411 |
0.344 |
|
| 2011 |
Block GA, Wolf M. Phosphate REINs in the renoprotective benefit of ACE inhibition. Journal of the American Society of Nephrology : Jasn. 22: 1777-9. PMID 21903991 DOI: 10.1681/Asn.2011080833 |
0.383 |
|
| 2011 |
Isakova T, Xie H, Barchi-Chung A, Vargas G, Sowden N, Houston J, Wahl P, Lundquist A, Epstein M, Smith K, Contreras G, Ortega L, Lenz O, Briones P, Egbert P, ... ... Wolf M, et al. Fibroblast growth factor 23 in patients undergoing peritoneal dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 2688-95. PMID 21903990 DOI: 10.2215/Cjn.04290511 |
0.478 |
|
| 2011 |
Wolf M. Should activated vitamin D be used in patients with end-stage renal disease and low levels of parathyroid hormone? Seminars in Dialysis. 24: 428-30. PMID 21851405 DOI: 10.1111/J.1525-139X.2011.00914.X |
0.408 |
|
| 2011 |
Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, ... ... Wolf M, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. Jama. 305: 2432-9. PMID 21673295 DOI: 10.1001/Jama.2011.826 |
0.492 |
|
| 2011 |
Wolf M, Molnar MZ, Amaral AP, Czira ME, Rudas A, Ujszaszi A, Kiss I, Rosivall L, Kosa J, Lakatos P, Kovesdy CP, Mucsi I. Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. Journal of the American Society of Nephrology : Jasn. 22: 956-66. PMID 21436289 DOI: 10.1681/Asn.2010080894 |
0.751 |
|
| 2011 |
Wu-Wong JR, Chen YW, Nakane M, Wolf M. Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 25: 215-22. PMID 21424825 DOI: 10.1007/S10557-011-6287-7 |
0.37 |
|
| 2011 |
Isakova T, Wahl P, Vargas GS, Gutiérrez OM, Scialla J, Xie H, Appleby D, Nessel L, Bellovich K, Chen J, Hamm L, Gadegbeku C, Horwitz E, Townsend RR, Anderson CA, ... ... Wolf M, et al. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney International. 79: 1370-8. PMID 21389978 DOI: 10.1038/Ki.2011.47 |
0.511 |
|
| 2011 |
Isakova T, Anderson CA, Leonard MB, Xie D, Gutiérrez OM, Rosen LK, Theurer J, Bellovich K, Steigerwalt SP, Tang I, Anderson AH, Townsend RR, He J, Feldman HI, Wolf M, et al. Diuretics, calciuria and secondary hyperparathyroidism in the Chronic Renal Insufficiency Cohort. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 1258-65. PMID 21382989 DOI: 10.1093/Ndt/Gfr026 |
0.47 |
|
| 2011 |
Kovesdy CP, Mucsi I, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Kim SJ, Wolf M, Molnar MZ. Association of serum phosphorus level with anemia in kidney transplant recipients. Transplantation. 91: 875-82. PMID 21358369 DOI: 10.1097/Tp.0B013E3182111Edf |
0.407 |
|
| 2011 |
Seeherunvong W, Wolf M. Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. Pediatric Transplantation. 15: 37-46. PMID 20946192 DOI: 10.1111/j.1399-3046.2010.01405.x |
0.309 |
|
| 2011 |
Isakova T, Gutiérrez OM, Patel NM, Andress DL, Wolf M, Levin A. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 21: 295-302. PMID 20817560 DOI: 10.1053/J.Jrn.2010.07.002 |
0.422 |
|
| 2011 |
Isakova T, Gutiérrez OM, Smith K, Epstein M, Keating LK, Jüppner H, Wolf M. Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 584-91. PMID 20631407 DOI: 10.1093/Ndt/Gfq419 |
0.44 |
|
| 2011 |
Gutiérrez OM, Isakova T, Enfield G, Wolf M. Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. Journal of Renal Nutrition : the Official Journal of the Council On Renal Nutrition of the National Kidney Foundation. 21: 140-8. PMID 20537917 DOI: 10.1053/J.Jrn.2010.03.001 |
0.347 |
|
| 2011 |
Houston J, Isakova T, Smith K, Sowden N, Wahl P, Wolf M, Gutiérrez O. 122 Relationships Between FGF23, Dietary Phosphorus, Urinary Phosphate and Vascular Stiffness American Journal of Kidney Diseases. 57. DOI: 10.1053/J.Ajkd.2011.02.125 |
0.319 |
|
| 2010 |
Gutiérrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH, Bellovich K, Chen J, Robinson N, Ojo A, Lash J, Feldman HI, Wolf M. Low socioeconomic status associates with higher serum phosphate irrespective of race. Journal of the American Society of Nephrology : Jasn. 21: 1953-60. PMID 20847142 DOI: 10.1681/Asn.2010020221 |
0.387 |
|
| 2010 |
Wolf M. FGF23: fashion or physiology? Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1727-9. PMID 20847097 DOI: 10.2215/Cjn.07410810 |
0.488 |
|
| 2010 |
Jüppner H, Wolf M, Salusky IB. FGF-23: More than a regulator of renal phosphate handling? Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 25: 2091-7. PMID 20593414 DOI: 10.1002/Jbmr.170 |
0.506 |
|
| 2010 |
Zisman AL, Wolf M. Recent advances in the rapidly evolving field of fibroblast growth factor 23 in chronic kidney disease. Current Opinion in Nephrology and Hypertension. 19: 335-42. PMID 20583336 DOI: 10.1097/MNH.0b013e328338f536 |
0.372 |
|
| 2010 |
Gutiérrez OM, Isakova T, Smith K, Epstein M, Patel N, Wolf M. Racial differences in postprandial mineral ion handling in health and in chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 3970-7. PMID 20530498 DOI: 10.1093/Ndt/Gfq316 |
0.418 |
|
| 2010 |
Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. Journal of the American Society of Nephrology : Jasn. 21: 1427-35. PMID 20507943 DOI: 10.1681/ASN.2009121293 |
0.422 |
|
| 2010 |
Szczech LA, Bregman DB, Harrington RA, Morris D, Butcher A, Koch TA, Goodnough LT, Wolf M, Onken JE. Randomized Evaluation of efficacy and safety of ferric carboxymaltose in Patients with iron deficiency Anaemia and Impaired Renal function (REPAIR-IDA): Rationale and study design Nephrology Dialysis Transplantation. 25: 2368-2375. PMID 20466657 DOI: 10.1093/Ndt/Gfq218 |
0.36 |
|
| 2010 |
Bhan I, Dubey A, Wolf M. Diagnosis and management of mineral metabolism in CKD. Journal of General Internal Medicine. 25: 710-6. PMID 20352364 DOI: 10.1007/S11606-010-1316-Y |
0.387 |
|
| 2010 |
Patel NM, Gutiérrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney International. 77: 715-20. PMID 20130525 DOI: 10.1038/Ki.2009.551 |
0.366 |
|
| 2010 |
Shimada T, Urakawa I, Isakova T, Yamazaki Y, Epstein M, Wesseling-Perry K, Wolf M, Salusky IB, Jüppner H. Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active. The Journal of Clinical Endocrinology and Metabolism. 95: 578-85. PMID 19965919 DOI: 10.1210/Jc.2009-1603 |
0.487 |
|
| 2010 |
Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, McCabe EL, Robins SJ, O'Donnell CJ, Hoffmann U, Jacques PF, Booth SL, Vasan RS, Wolf M, Wang TJ. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 59: 242-8. PMID 19833894 DOI: 10.2337/Db09-1011 |
0.318 |
|
| 2010 |
Warsch JRL, Wolf M, Wright CB. Chronic kidney disease in patients with cognitive impairment: A marker of microvascular damage or an independent risk factor? Aging Health. 6: 423-427. DOI: 10.2217/Ahe.10.47 |
0.35 |
|
| 2010 |
Isakova T, Gutiérrez OM, Wolf M. Response to 'Targeting hyperphosphatemia: truth or dare' Kidney International. 77: 257. DOI: 10.1038/Ki.2009.448 |
0.301 |
|
| 2009 |
Wolf M. Second chances in mineral metabolism. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 1-3. PMID 20007676 DOI: 10.2215/Cjn.08131109 |
0.4 |
|
| 2009 |
Wolf M. Fibroblast growth factor 23 and the future of phosphorus management. Current Opinion in Nephrology and Hypertension. 18: 463-8. PMID 19770756 DOI: 10.1097/MNH.0b013e328331a8c8 |
0.341 |
|
| 2009 |
Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney International. 76: 977-83. PMID 19657329 DOI: 10.1038/ki.2009.288 |
0.365 |
|
| 2009 |
Isakova T, Gutiérrez OM, Wolf M. A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease. Kidney International. 76: 705-16. PMID 19606082 DOI: 10.1038/Ki.2009.246 |
0.436 |
|
| 2009 |
Friedman DJ, Afkarian M, Tamez H, Bhan I, Isakova T, Wolf M, Ankers E, Ye J, Tonelli M, Zoccali C, Kuro-o M, Moe O, Karumanchi SA, Thadhani R. Klotho variants and chronic hemodialysis mortality Journal of Bone and Mineral Research. 24: 1847-1855. PMID 19419323 DOI: 10.1359/Jbmr.090516 |
0.4 |
|
| 2009 |
Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 119: 2545-52. PMID 19414634 DOI: 10.1161/Circulationaha.108.844506 |
0.471 |
|
| 2009 |
Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. Journal of the American Society of Nephrology : Jasn. 20: 1140-8. PMID 19389844 DOI: 10.1681/Asn.2008091008 |
0.331 |
|
| 2009 |
Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. Journal of the American Society of Nephrology : Jasn. 20: 388-96. PMID 19092121 DOI: 10.1681/Asn.2008060609 |
0.367 |
|
| 2008 |
Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. The New England Journal of Medicine. 359: 584-92. PMID 18687639 DOI: 10.1056/Nejmoa0706130 |
0.488 |
|
| 2008 |
Gutiérrez OM, Tamez H, Bhan I, Zazra J, Tonelli M, Wolf M, Januzzi JL, Chang Y, Thadhani R. N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in hemodialysis patients: prognostic value of baseline and follow-up measurements. Clinical Chemistry. 54: 1339-1348. PMID 18539645 DOI: 10.1373/Clinchem.2007.101691 |
0.329 |
|
| 2008 |
Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from Nonuremic Causes: A Systematic Review Clinical Journal of the American Society of Nephrology. 3: 1139-1143. PMID 18417747 DOI: 10.2215/Cjn.00530108 |
0.389 |
|
| 2008 |
Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R. Impact of activated vitamin D and race on survival among hemodialysis patients. Journal of the American Society of Nephrology : Jasn. 19: 1379-88. PMID 18400938 DOI: 10.1681/Asn.2007091002 |
0.324 |
|
| 2008 |
Gutiérrez OM, Isakova T, Andress DL, Levin A, Wolf M. Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease Kidney International. 73: 956-962. PMID 18256597 DOI: 10.1038/Ki.2008.4 |
0.411 |
|
| 2008 |
Isakova T, Gutierrez O, Shah A, Castaldo L, Holmes J, Lee H, Wolf M. Postprandial mineral metabolism and secondary hyperparathyroidism in early CKD. Journal of the American Society of Nephrology : Jasn. 19: 615-23. PMID 18216315 DOI: 10.1681/Asn.2007060673 |
0.465 |
|
| 2008 |
Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M, Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 117: 503-11. PMID 18180395 DOI: 10.1161/Circulationaha.107.706127 |
0.329 |
|
| 2007 |
Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney International. 72: 1004-13. PMID 17687259 DOI: 10.1038/Sj.Ki.5002451 |
0.342 |
|
| 2007 |
Wolf M, Thadhani R. Vitamin D in patients with renal failure: a summary of observational mortality studies and steps moving forward. The Journal of Steroid Biochemistry and Molecular Biology. 103: 487-90. PMID 17197169 DOI: 10.1016/J.Jsbmb.2006.11.009 |
0.335 |
|
| 2006 |
Bhan I, Shah A, Holmes J, Isakova T, Gutierrez O, Burnett SM, Jüppner H, Wolf M. Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'? Kidney International. 70: 1486-94. PMID 16941023 DOI: 10.1038/Sj.Ki.5001788 |
0.349 |
|
| 2005 |
Wolf M, Thadhani R. Beyond minerals and parathyroid hormone: role of active vitamin D in end-stage renal disease. Seminars in Dialysis. 18: 302-6. PMID 16076353 DOI: 10.1111/J.1525-139X.2005.18406.X |
0.374 |
|
| 2005 |
Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Jüppner H, Wolf M. Fibroblast Growth Factor-23 Mitigates Hyperphosphatemia but Accentuates Calcitriol Deficiency in Chronic Kidney Disease Journal of the American Society of Nephrology. 16: 2205-2215. PMID 15917335 DOI: 10.1681/Asn.2005010052 |
0.511 |
|
| 2005 |
Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA, Thadhani R. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. Journal of the American Society of Nephrology : Jasn. 16: 1115-25. PMID 15728786 DOI: 10.1681/Asn.2004070573 |
0.323 |
|
| 2004 |
Wieland A, Mehta A, Greenfield A, Wolf M. Temporary suprarenal inferior vena cava filter for renal biopsy in a patient with renal vein thrombosis. Clinical Nephrology. 62: 239-241. PMID 15481858 DOI: 10.5414/Cnp62239 |
0.322 |
|
| 2003 |
Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. The New England Journal of Medicine. 349: 446-56. PMID 12890843 DOI: 10.1056/Nejmoa022536 |
0.343 |
|
| 2002 |
Thadhani R, Wolf M, West ML, Tonelli M, Ruthazer R, Pastores GM, Obrador GT. Patients with Fabry disease on dialysis in the United States. Kidney International. 61: 249-55. PMID 11786107 DOI: 10.1046/J.1523-1755.2002.00097.X |
0.352 |
|
| Show low-probability matches. |